Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07291427 · ClinicalTrials.gov registry record
Chronic Subdural Hematoma Embolization With Detachable Coils
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- 150
- Enrollment target
NCT07291427 is a clinical trial that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants.
The verdict
NCT07291427 has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
Interventions
- DEVICE Balt coils: (Balt USA, LLC)
- PROCEDURE MMA embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07291427
The ClinicalTrials.gov registry entry for NCT07291427 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Balt coils: (Balt USA, LLC) is the first listed.
NCT07291427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07291427 about?
NCT07291427 is a clinical study titled "Chronic Subdural Hematoma Embolization With Detachable Coils". This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
What is the current status of trial NCT07291427?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2026-07-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT07291427?
The interventions under investigation include: Balt coils: (Balt USA, LLC) (DEVICE), MMA embolization (PROCEDURE).
Who is sponsoring clinical trial NCT07291427?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.